MK-3682B

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-3682B, covering 2018-12-14 to 2018-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030) [Phase 1]